UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Kierkegaard: Sobre el proceso y la paradoja en Temor y temblor

Revista de filosofía (México), 2020-12, Vol.53 (150), p.44-72

2020

Volltextzugriff (PDF)

Dating the late Miocene marine sediments around the southern middle Durance valley (Provence, SE France): new evidences for a Tortonian age

Bulletin de la Société géologique de France, 2024-01, Vol.195, p.14

2024

Volltextzugriff (PDF)

Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration

Pharmacogenomics, 2012-07, Vol.13 (9), p.1037-1053

2012

Volltextzugriff (PDF)

Kierkegaard: Sobre el proceso y la paradoja en Temor y temblor

Revista de filosofía (México), 2021, Vol.53 (150), p.44-72

Alison Assiter, Anna Fioravanti

2021

Volltextzugriff (PDF)

Modelling of a lined tyre for predicting cavity noise mitigation

Applied acoustics, 2019-12, Vol.155, p.391-400

2019

Volltextzugriff (PDF)

1,2-Benzisothiazole Derivatives Bearing 4‑, 5‑, or 6‑Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions

Journal of medicinal chemistry, 2016-07, Vol.59 (13), p.6547-6552

2016

Volltextzugriff (PDF)

Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo

Oncology reports, 2018-05, Vol.39 (5), p.2306-2314

2018

Volltextzugriff (PDF)

Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies

Journal of medicinal chemistry, 2014-02, Vol.57 (4), p.1225-1235

2014

Volltextzugriff (PDF)

CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo

Molecular and cellular endocrinology, 2014-08, Vol.393 (1-2), p.56-64

2014

Volltextzugriff (PDF)

Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2

European journal of medicinal chemistry, 2015-10, Vol.103, p.29-43

2015

Volltextzugriff (PDF)

The effect of osteogenic growth peptide (OGP) on proliferation and adhesion of HEMC-1 human endothelial cells

Pharmacological research, 2002-01, Vol.45 (1), p.21-25

2002

Volltextzugriff (PDF)

Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells

Biochemical pharmacology, 2011-06, Vol.81 (11), p.1309-1316

2011

Volltextzugriff (PDF)

First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study

Investigational new drugs, 2012-08, Vol.30 (4), p.1725-1730

2012

Volltextzugriff (PDF)

Abstract 4375: Sunitinib alone and in combination with SN-38 is active against anaplastic thyroid cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4375-4375

2012

Volltextzugriff (PDF)

A new biometric tool for three-dimensional subcutaneous tumor scanning in mice

In vivo (Athens), 2014-01, Vol.28 (1), p.75-80

2014

Volltextzugriff (PDF)

Overexpression and Functional Relevance of Somatostatin Receptor-1, -2, and -5 in Endometrium and Endometriotic Lesions

The journal of clinical endocrinology and metabolism, 2010-12, Vol.95 (12), p.5315-5319

2010

Volltextzugriff (PDF)

Metronomic capecitabine (cape) and cyclophosphamide (CTX) for refractory metastatic colorectal cancer (mCRC): Results of a phase II trial

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e14577-e14577

2013

Volltextzugriff (PDF)

Prospective analysis of the early modulation of plasma amphiregulin (AR) during treatment with cetuximab and irinotecan in irinotecan-refractory metastatic colorectal cancer (mCRC) patients (pts)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3602-3602

2013

Volltextzugriff (PDF)

Circulating angiogenic factors as predictors of benefit from bevacizumab (bev) beyond progression in metastatic colorectal cancer (mCRC): Traslational analyses from the phase III BEBYP trial

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3603-3603

2013

Volltextzugriff (PDF)

Prospective Analysis of the Early Modulation of Plasma Amphiregulin During Treatment with Cetuximab and Irinotecan in Metastatic Colorectal Cancer Patients

Annals of oncology, 2013-06, Vol.24, p.iv28-iv28

2013

Volltextzugriff (PDF)

Circulating angiogenic factors as predictors of benefit from bevacizumab (bev) beyond progression in metastatic colorectal cancer (mCRC): Translational analyses from the phase III BEBYP trial

Journal of clinical oncology, 2013-02, Vol.31 (4_suppl), p.382-382

2013

Volltextzugriff (PDF)

Metronomic Ceramide Analogs Inhibit Angiogenesis in Pancreatic Cancer through Up-regulation of Caveolin-1 and Thrombospondin-1 and Down-regulation of Cyclin D112

Neoplasia (New York, N.Y.), 2012-09, Vol.14 (9), p.833-845

2012

Volltextzugriff (PDF)

Pharmacogenetic interaction analysis of

Pharmacogenomics, 2014-12, Vol.15 (16), p.1985-1999

2014

Volltextzugriff (PDF)

Irinotecan Synergistically Enhances the Antiproliferative and Proapoptotic Effects of Axitinib In Vitro and Improves Its Anticancer Activity In Vivo1

Neoplasia (New York, N.Y.), 2011-03, Vol.13 (3), p.217-229

2011

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(72)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(34)
Humans
(21)
Pharmacology & Pharmacy
(13)
Physical Sciences
(11)
Technology
(11)
Chemistry
(10)
Chemistry, Medicinal
(7)
Animals
(6)
Antineoplastic Agents - Pharmacology
(6)
Chemistry, Multidisciplinary
(6)
Clinical Trials
(6)
Engineering
(6)
Medicine
(6)
Medicine & Public Health
(6)
Patients
(6)
Bevacizumab
(5)
Cell Line, Tumor
(5)
Cell Proliferation - Drug Effects
(5)
Dose-Response Relationship, Drug
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Kierkegaard: Sobre el proceso y la paradoja en Temor y temblor

Dating the late Miocene marine sediments around the southern middle Durance valley (Provence, SE France): new evidences for a Tortonian age

Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration

Kierkegaard: Sobre el proceso y la paradoja en Temor y temblor

Modelling of a lined tyre for predicting cavity noise mitigation

1,2-Benzisothiazole Derivatives Bearing 4‑, 5‑, or 6‑Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions

Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo

Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies

CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo

Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2

The effect of osteogenic growth peptide (OGP) on proliferation and adhesion of HEMC-1 human endothelial cells

Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells

First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study

Abstract 4375: Sunitinib alone and in combination with SN-38 is active against anaplastic thyroid cancer

A new biometric tool for three-dimensional subcutaneous tumor scanning in mice

Overexpression and Functional Relevance of Somatostatin Receptor-1, -2, and -5 in Endometrium and Endometriotic Lesions

Metronomic capecitabine (cape) and cyclophosphamide (CTX) for refractory metastatic colorectal cancer (mCRC): Results of a phase II trial

Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab

Prospective analysis of the early modulation of plasma amphiregulin (AR) during treatment with cetuximab and irinotecan in irinotecan-refractory metastatic colorectal cancer (mCRC) patients (pts)

Circulating angiogenic factors as predictors of benefit from bevacizumab (bev) beyond progression in metastatic colorectal cancer (mCRC): Traslational analyses from the phase III BEBYP trial

Prospective Analysis of the Early Modulation of Plasma Amphiregulin During Treatment with Cetuximab and Irinotecan in Metastatic Colorectal Cancer Patients

Circulating angiogenic factors as predictors of benefit from bevacizumab (bev) beyond progression in metastatic colorectal cancer (mCRC): Translational analyses from the phase III BEBYP trial

Metronomic Ceramide Analogs Inhibit Angiogenesis in Pancreatic Cancer through Up-regulation of Caveolin-1 and Thrombospondin-1 and Down-regulation of Cyclin D112

Pharmacogenetic interaction analysis of

Irinotecan Synergistically Enhances the Antiproliferative and Proapoptotic Effects of Axitinib In Vitro and Improves Its Anticancer Activity In Vivo1

Aktive Filter

Suchergebnisse filtern